Astral Systems logo

Astral Systems

Develops deep-tech systems to support the commercial production and availability of medical isotopes for healthcare markets.

Deep Tech
Medical Isotopes
Total Raised
€26M
Headquarters
Bristol, United Kingdom

Overview

Astral Systems is a Bristol-based deep tech company focused on supporting the commercialisation of medical isotopes. Its work targets healthcare and related medical supply chains that depend on reliable access to isotope materials. The company raised a €26 million Series A in June 2026 to advance medical isotope commercialisation. The financing positions Astral Systems to scale its offering from Bristol and address demand in a specialized market where production capability and supply reliability are key differentiators.

Funding History

1 round · Jun 2026
€26M
Total Raised
1
Cumulative: €26M

Bristol’s Astral Systems secures €26 million Series A to support medical isotope commercialisation

Mercia Ventures (Lead)Tees RiverDaphniBlast ClubSpeedinvestPlayfair
Source

Frequently Asked Questions

How much funding does AI Funding track for Astral Systems?
AI Funding tracks €26M for Astral Systems across 1 funding round in this database.
Who are Astral Systems's investors?
Astral Systems's investors include Speedinvest, Daphni, Mercia Ventures, Tees River, Blast Club, and 1 others.
What does Astral Systems do?
Astral Systems is a Bristol-based deep tech company focused on supporting the commercialisation of medical isotopes. Its work targets healthcare and related medical supply chains that depend on reliable access to isotope materials. The company raised a €26 million Series A in June 2026 to advance medical isotope commercialisation. The financing positions Astral Systems to scale its offering from Bristol and address demand in a specialized market where production capability and supply reliability are key differentiators.
Where is Astral Systems headquartered?
Astral Systems is headquartered in Bristol, United Kingdom.